Technology

Blocker Displacement
Amplification

Rare allele enrichment technology by PCR that enables the selective amplification and detection of low-abundant sequence variants down to 0.01% variant allele frequency (VAF).

Quantitative Amplicon
Sequencing

NGS-based method that utilizes unique molecular identifiers (UMIs) and highly multiplexed partially nested PCR primer design to detect mutations and copy number variations with high sensitivity.

Accelerating Precision Oncology Worldwide

Clinical and Research Laboratories

At NuProbe, we are developing innovative assays to accelerate cancer research. Our products allow laboratories to detect and quantify low-abundant variants across multiple platforms from both cell-free DNA and tissue specimens. Contact us today to learn more.

Pharma

We provide assay development and testing services to support all stages of biomarker detection programs. Our flexible platform utilizes proprietary technologies to deliver best-in-class sensitivity from solid tumor and liquid biopsy. Contact one of our experts today to find out what NuProbe can do for you.

Never miss an update

Stay in touch for the latest NuProbe developments

Subscribe





    News & Press Releases

    Upcoming Events

    SEPT 26-29, 2022
    World CB & CDx

    NOV 01-05, 2022
    AMP Annual Meeting

    DEC 10-13, 2022
    ASH Annual Meeting

      Request A Quote





      X